MustGrow Team

Corey is an entrepreneur who has been focused on the agriculture, potash, oil and gas, mining, and real estate industries specifically in his home province of Saskatchewan, for the past 20 years. He is co-founder and director of Legacy Capital Corp., which is a private equity company focused on participating in management buyouts of strong sustainable cash flowing businesses.

In 2009, Corey co-founded a Saskatchewan based heavy oil company, Rallyemont Energy Inc., where he served as President and CEO. Rallyemont successfully explored for and delineated the Prince Thermal Heavy Oil Project and sold to Husky Energy in December 2013. Prior to Rallyemont, Corey was an independent consultant to a group of companies, including PanWestern Energy Inc. (TSXV-PW), Infrastructure Materials Corp. (OTCBB-IFAM), and Anglo Potash Ltd. (TSXV-AGP), which was formerly Anglo Minerals Ltd. (TSXV-ALM). At Anglo, he held the title of Vice President, Business Development and Investor Relations and was instrumental in marketing the company across Canada and into Europe. Anglo was acquired by its joint venture partner, BHP Billiton, in July 2008 for $284 million.

Prior to joining Anglo, Mr. Giasson was employed by PotashCorp, where he held the title of Manager, Market Research. He has a MBA and B.Sc. in Agriculture Economics, both from the University of Saskatchewan.

Colin Bletsky's roots trace back to Eastern Saskatchewan, where he was raised on a third-generation family farm cultivating canola, cereals, and peas. This rich agricultural tradition persists as he and his family actively engage in farming activities during seeding and harvest seasons. Today, Colin dedicates most of his time to advancing sustainable agriculture on a global scale.

Currently serving as the Chief Operating Officer at MustGrow Biologics Corp., Colin plays a pivotal role in empowering growers with natural, science-based technologies to enhance food production. His passion for harnessing the potential of natural solutions extends beyond MustGrow, as he collaborates with producers and consumers across various industries to showcase the benefits of leveraging nature in food production, shipping, and storage.

In his previous role as Vice President at Novozymes, Colin spearheaded the management of the company's global BioAg business, ensuring sustainable growth for Novozymes and its partners. As a strategic leader, he formulated and directed the company's overarching strategy, fostering collaboration with internal and external stakeholders. Colin also served as a key member of the Monsanto and Novozymes Alliance board. His extensive experience with Novozymes from 2010 to 2014 included contributions to BioAg Business Development and Account Management across North America, South America, Australia, Europe, and Asia.

Colin's journey in the agricultural sector began in the late '90s, gaining valuable experience in the retail and seed industry with notable companies like Pioneer in rural Saskatchewan. Over the next decade, he honed his management and project skills in sales and marketing within the crop protection industry, notably with Syngenta.

Beyond his impressive three decades in agricultural business, Colin holds a Bachelor of Science in Agriculture from the University of Saskatchewan. He has also pursued executive education at both the London School of Business and INSEAD, further enhancing his leadership capabilities. Additionally, he was a Certified Crop Advisor, showcasing his commitment to expertise and excellence in the field.

Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. Prior to this, he was Treasurer of PartnerRe Ltd., one of the largest reinsurance companies in the world. There he participated in large international mergers and acquisitions and financing initiatives and had responsibilities in investment management, investor relations, capital management and financial operations. He has closed over 50 mergers and acquisitions, financing and licensing transactions totalling over USD $2.4 billion. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

With 35 years of leadership experience in agricultural management, agricultural biotechnology, and business development, Ben Libby is a results-driven executive known for transforming innovative ideas into measurable outcomes. Most recently serving as General Manager at NexusBioAg under Univar Solutions, Ben played a pivotal role in spearheading strategic initiatives that redefined market value and drove organizational growth. His career is marked by influential positions at Novozymes BioAg, BASF, and Becker Underwood, where he demonstrated exceptional prowess in global commercial development, strategic partnerships, and market expansion. Ben’s leadership style combines entrepreneurial instinct with structured executive management, fostering an environment of accountability, innovation, and collaborative success. A champion of efficient decision-making and forward-thinking strategies, Ben remains dedicated to achieving impactful, legacy-worthy outcomes in every role he undertakes.

Mr. Brad Munro is an independent businessperson and President and Chief Executive Officer of Bittercreek Capital Corporation, a private investment firm, since 2006. From 1991 to 2009, Mr. Munro served in senior investment roles in the private equity/venture capital industry in Canada. Mr. Munro holds a Bachelor of Commerce degree from the University of Saskatchewan and has 30 years of experience in investment management, board and c-suite management across a wide variety of industries. Mr. Munro has served as a Director of a number of public companies over the past 30 years, both TSX and Venture listed entities, as Chair and Lead Director.

David is currently Chief Financial Officer at ApplyBoard Inc, a technology company that offers a artificial intelligence recruitment platform to help international students apply for post-secondary studies abroad.

Prior to ApplyBoard, David was Chief Financial Officer at Impossible Foods Inc., a company that develops plant-based meat alternatives, from 2021 to 2023, and VP, Chief Accounting Officer from 2019 to 2021.

David has also held various senior financial leadership roles in Finance, Accounting, Treasury, and Corporate Development, at Stripe Inc, Square Inc, and OpenText Corp, where he helped these technology company scale their various finance functions as both private and public companies. Most notably, David helped lead Square through their IPO registration process in 2015.

David holds an honors degree in business from Wilfrid Laurier University and a Masters degree from the Schulich School of Business at York University.  He is a Canadian Chartered Accountant, a U.S. Certified Public Accountant.

Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. He became president of Natural Industries, a family founded business focused on biological pest control, from 2002-2012. Under his leadership, Natural Industries was awarded five EPA registrations; three biofungicides, a bionematicide and a bioinsecticide. He worked closely with researchers, distributors and growers, pioneering the effort to educate the industry and push for a wider adoption of biologicals as whole. In addition, Matt spearheaded international distribution and long-term strategic partnerships, decisively positioning the company for global expansion.

Matt directly implemented the launch of Actinovate®, Natural Industries’ flagship product, and shepherded it to become one of the premiere biofungicides in the fruit and vegetable market. Growth at Natural Industries was intentionally methodical, fueled only by cash flow with no infusion of outside capital. By 2012 Natural Industries had 26 employees, no debt and was growing organically at 20-40% per year.

In November 2012, Matt led the strategic sale of Natural Industries to Novozymes BioAg. At Novozymes, he became part of the Global Business Development team taking his place as the biocontrol manager for Novozymes. Matt left Novozymes in April of 2015. His current investments, which include real estate, hospitality, and biotechnology, are directed through his investment corporation, Stronghold Keep. He also sits on the board of directors for VRM Labs, a startup that has a patented natural antioxidant preservative for pet and animal feed.

Tom Flow is currently the Managing Director of Holigen, a medical cannabis company based in Portugal and owned by Akanda Corp, a Nasdaq listed company. Tom has held several C-level executive roles at Canadian cannabis companies including; The Flowr Corporation and MedReleaf Corp. which was recently sold for $3.2B. Tom is an advisor and sits on the board of several cannabis companies. He is widely-recognised for cannabis thought leadership and expertise building and operating cannabis cultivation facilities.